SOHO Global Health is one of Indonesia's leading pharmaceutical and healthcare corporations in manufacturing, distributing, and providing quality health products and services.
SOHO Global Health consists of 2 synergy business units: Healthcare Business Unit and Commercial Business Unit thus are supported by Support Functions Unit consist of Finance, Human Capital Development & Public Affair, Business Technology, Legal Compliance, Supply & Operations, Office of Strategy Management and Corporate Secretary.
We focus on manufacturing - including under-licensed - herbal products (immunomodulator, antioxidant, anti diarrhea, anti laxantia) and synthetic products (antibiotic, cephalosporin, injection preparation, antiemetic, analgesic, musculoskeletal, vitamin, obgyn, gastro, neuro, and rheumatology products)
We distribute pharmaceutical and healthcare products of our companies, and other pharmaceutical and consumer goods manufacturers.
Our distribution channel is supported by our branches covering 90% of major cities in Indonesia.
Our global presence in emerging markets: Malaysia, Myanmar, Nigeria, Lebanon, Mongolia, Vietnam, Suriname, Brunei, Mauritius, Sri Lanka, Pakistan.
We employ around 6,000 people.
In 2005 we started adopting Balanced Scorecard framework to translate strategy into operational objectives that drive both behavior and performance.
We have been investing heavily in Product Development, Human Capital and Information Capital in order to improve and upgrade these aspects across the organization since 2005.
We are committed to VISION 2015: New Horizon Strategy to create our future together.